PAZOPANIB HF

Film-coated tablet, 400mg
RxActive license

Active substance (INN)

pazopanib

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength400mg
PackagingUkupno 1 bočica plastična sa 60 film tableta u kartonskoj kutiji.
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX03)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateNovember 24, 2022

Analogs in Montenegro

16

Other medicines with the same active substance

FRONTIENTRx
Film-coated tablet, 400mgPharmacare Premium Ltd.
FRONTIENTRx
Film-coated tablet, 200mgPharmacare Premium Ltd.
LIBURADONERx
Film-coated tablet, 200mgPharmacare Premium Ltd.
LIBURADONERx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PARIZOLRx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PARIZOLRx
Film-coated tablet, 200 mgPharmacare Premium Ltd.
PAZOPANIB HFRx
Film-coated tablet, 200mgStada Arzneimittel AG
PAZOPANIB HFRx
Film-coated tablet, 200mgStada Arzneimittel AG
PAZOPANIB SKRx
Film-coated tablet, 400mgPharmacare Premium Ltd.
PAZOPANIB SKRx
Film-coated tablet, 200mgPharmacare Premium Ltd.
PAZOPANIB TEVARestricted
Film-coated tablet, 200mgRemedica Ltd.
PAZOPANIB TEVARestricted
Film-coated tablet, 400mgRemedica Ltd.
PAZOPANIB ZENTIVARx
Film-coated tablet, 200mgRemedica Ltd.
PAZOPANIB ZENTIVARx
Film-coated tablet, 400mgRemedica Ltd.
VOTRIENTRx
Film-coated tablet, 400mgGlaxo Wellcome S.A.
VOTRIENTRx
Film-coated tablet, 200mgGlaxo Wellcome S.A.
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026